| 产品描述: | RALA peptide is a cationic amphiphilic delivery agent targeting cell membranes, which forms nanoparticles through electrostatic interactions with anionic drugs. RALA peptide has pH-responsive binding properties, which can enhance the α-helical conformation in an acidic environment and destroy the endosomal membrane, promote the release of drugs into the cytoplasm, and exert efficient intracellular delivery activity. RALA peptide can be used in cancer research (enhancing the activity of bisphosphonates against prostate cancer and breast cancer cells) and bone tissue engineering (promoting osteoblast collagen deposition and extracellular matrix mineralization). |
| 体内研究: |
RALA peptide (10 μg 阿仑膦酸盐/次;瘤内注射;3 次/周;共 3 周) 在 PC3 荷瘤小鼠模型中显著延缓肿瘤生长,延长小鼠中位生存时间至 26 天 (对照组 16 天),证实 RALA/阿仑膦酸盐纳米颗粒通过增强药物递送提升体内抗肿瘤效果。 RALA peptide (复合 α-TCP 纳米颗粒;皮下植入;单次植入;体内植入 8 周) 在 Balb/C 裸鼠模型中促进成骨分化和血管化实现高效骨组织再生,诱导间充质干细胞负载的水凝胶内骨组织形成,矿化体积与生长因子递送组无显著差异 웿 |
| 保存条件: |
-80°C, 干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.3 ml |
1.502 ml |
3.005 ml |
| 5 mM |
0.06 ml |
0.3 ml |
0.601 ml |
| 10 mM |
0.03 ml |
0.15 ml |
0.3 ml |
| 50 mM |
0.006 ml |
0.03 ml |
0.06 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |